← back to search

Stacy J. Caillier

University of California, San Francisco · US
Area of research
Pathology and Forensic Medicine · Immunology
Research interest
Research interests include Multiple Sclerosis Research Studies, T-cell and B-cell Immunology, Immune Cell Function and Interaction, and Olfactory and Sensory Function Studies.
h-index
47
citations
10,193
works
112
NIH funding
primary concept
Biology
email

Recent publications

Shared Epitope-Positive <i>HLA</i> Alleles Protect Against Alpha-Synuclein Pathology in a Model of Parkinson Disease.
2026cited by 0position: contributordoi
Development of a Diagnostic Autoantibody Assay to a Consensus Motif for the Risk Prediction of Epstein-Barr Virus-Related Multiple Sclerosis.
2026cited by 0position: contributordoi
Epigenetic Aging in Pediatric-Onset Multiple Sclerosis
Neurology 2025cited by 7position: middledoi
HLA-A∗03:01 as predictive genetic biomarker for glatiramer acetate treatment response in multiple sclerosis: a retrospective cohort analysis
EBioMedicine 2025cited by 5position: middledoi
Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect clinical and radiographic disease activity in multiple sclerosis
Nature Communications 2024cited by 27position: middledoi
Locus for severity implicates CNS resilience in progression of multiple sclerosis
Nature 2023cited by 217position: middledoi
Neurofilament Light Chain Elevation and Disability Progression in Multiple Sclerosis
JAMA Neurology 2023cited by 85position: middledoi
Gut microbiome of multiple sclerosis patients and paired household healthy controls reveal associations with disease risk and course
Cell 2022cited by 299position: middledoi
Polygenic risk score association with multiple sclerosis susceptibility and phenotype in Europeans
Brain 2022cited by 59position: middledoi
High-Resolution Characterization of KIR Genes in a Large North American Cohort Reveals Novel Details of Structural and Sequence Diversity
Frontiers in Immunology 2021cited by 37position: middledoi
Specific hypomethylation programs underpin B cell activation in early multiple sclerosis.
2021cited by 23position: contributordoi
Next-Generation Sequencing Identifies Extended HLA Class I and II Haplotypes Associated With Early-Onset and Late-Onset Myasthenia Gravis in Italian, Norwegian, and Swedish Populations
Frontiers in Immunology 2021cited by 19position: middledoi
Ataxin-1 regulates B cell function and the severity of autoimmune experimental encephalomyelitis
Proceedings of the National Academy of Sciences 2020cited by 46position: middledoi
Killer Cell Immunoglobulin-like Receptor Variants Are Associated with Protection from Symptoms Associated with More Severe Course in Parkinson Disease
The Journal of Immunology 2020cited by 28position: middledoi
Association Between Serum Neurofilament Light Chain Levels and Long-term Disease Course Among Patients With Multiple Sclerosis Followed up for 12 Years
JAMA Neurology 2019cited by 193position: middledoi
A systems biology approach uncovers cell-specific gene regulatory effects of genetic associations in multiple sclerosis
Nature Communications 2019cited by 82position: middledoi
A specific amino acid motif of<i>HLA-DRB1</i>mediates risk and interacts with smoking history in Parkinson’s disease
Proceedings of the National Academy of Sciences 2019cited by 80position: middledoi
Telomere Length Is Associated with Disability Progression in Multiple Sclerosis
Annals of Neurology 2019cited by 74position: middledoi
Next-generation sequencing reveals new information about HLA allele and haplotype diversity in a large European American population
Human Immunology 2019cited by 59position: middledoi
mi<scp>RNA</scp>contributions to pediatric‐onset multiple sclerosis inferred from<scp>GWAS</scp>
Annals of Clinical and Translational Neurology 2019cited by 15position: middledoi
Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk
Cell 2018cited by 171position: middledoi
Genome sequencing uncovers phenocopies in primary progressive multiple sclerosis
Annals of Neurology 2018cited by 55position: middledoi
Evidence for a causal relationship between low vitamin D, high BMI, and pediatric-onset MS
Neurology 2017cited by 161position: middledoi
MIF and D-DT are potential disease severity modifiers in male MS subjects
Proceedings of the National Academy of Sciences 2017cited by 99position: middledoi
Ovarian aging is associated with gray matter volume and disability in women with MS
Neurology 2017cited by 68position: middledoi
Genetic risk factors for pediatric-onset multiple sclerosis
Multiple Sclerosis Journal 2017cited by 59position: middledoi
P088 Haplotype analyses of classical HLA genes from families
Human Immunology 2017cited by 0position: middledoi
Long‐term evolution of multiple sclerosis disability in the treatment era
Annals of Neurology 2016cited by 434position: middledoi
Association of HLA Genetic Risk Burden With Disease Phenotypes in Multiple Sclerosis
JAMA Neurology 2016cited by 90position: middledoi
An ImmunoChip study of multiple sclerosis risk in African Americans
Brain 2015cited by 78position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jorge R. Oksenberg · University of San Francisco16 papers (2013–2021)Adam Santaniello · Adaptive Biotechnologies (United States)10 papers (2013–2024)Stephen L. Hauser · University of California, San Francisco9 papers (2013–2024)Bruce Cree · California State University, Bakersfield8 papers (2013–2026)Jill A. Hollenbach · University of California, San Francisco7 papers (2016–2021)Marcelo Fernández-Viña · Palo Alto University6 papers (2017–2021)Lisa E. Creary · Palo Alto University5 papers (2017–2021)Sergio E. Baranzini · Institute of Bioinformatics4 papers (2013–2024)Gonzalo Montero-Martín · Palo Alto University4 papers (2019–2021)Roland G. Henry · University of Pavia4 papers (2016–2024) · 3 papers (2017–2021)Ravi Dandekar · City College of San Francisco3 papers (2019–2021) · 3 papers (2021–2026)Chao Zhao · Xuzhou Medical College3 papers (2019–2020)Neda Nemat‐Gorgani · Palo Alto University3 papers (2019–2021)Noriko Isobe · Kyushu University3 papers (2013–2016)Paul J. Norman · University of Colorado Denver3 papers (2019–2021)Wesley M. Marin · University of California, San Francisco3 papers (2019–2021)Hengameh Shams · University of California, Berkeley3 papers (2020–2021)Pierre‐Antoine Gourraud · Inserm3 papers (2013–2016)